FDA Clears AstraZeneca’s COVID-19 Antibody Treatment For Immunocompromised
The Food and Drug Administration authorized the first injectable monoclonal antibody cocktail for long-term prevention of Covid-19 among people with weakened immune systems before they have been exposed to the coronavirus. NBC News reports: The FDA issued an emergency use authorization Wednesday for AstraZeneca’s antibody cocktail, Evusheld, for what is Read more…






